Marvin C. Gershengorn, M.D.

Special Volunteer: Laboratory of Endocrinology & Receptor Biology

Scientific Focus Areas: Cell Biology, Molecular Pharmacology

marvin.gershengorn@nih.gov 301-792-3074 Add to Contacts

Research Materials

1. Adenovirus gene expression system (U.S. Patent Number 6,824,770)

   The invention is directed to an adenoviral vector comprising (a) at least one insertion site for cloning a heterologous gene, and, in an orientation opposite to the direction of transcription of the adenoviral region into which it is inserted, (b) a…
   Summary
   PI: Gershengorn, Marvin

2. Inverse agonists & neutral antagonists for the tsh receptor (U.S. Patent Application Number WO 2011127388 A2)

   TSHR inverse agonists and neutral antagonists that are useful for treating Graves' orbitopathy, Graves' hyperthyroidism and/or thyroid cancer
   Summary
   PI: Gershengorn, Marvin; Neumann, Susanne

3. Low molecular weight thyroid stimulating hormone receptor (tshr) agonists (U.S. Patent Application Number WO 2010047674 A1)

   NIH investigators have discovered a series of low molecular weight thyroid-stimulating hormone (TSH) receptor modulators for use in the procedure to detect residual thyroid cancer cells following thyroidectomy. As small molecules, these compounds are…
   Summary
   PI: Gershengorn, Marvin; Neumann, Susanne

4. Methods of identifying negative antagonists for G protein coupled receptors (U.S. Patent Number 6,087,115)

   The present invention is directed to a constitutively active G protein coupled receptor of human herpesvirus 8, as well as a method of identifying negative antagonists of a constitutively active G protein coupled receptor. The method comprises…
   Summary
   PI: Gershengorn, Marvin

5. Methods of identifying peptide agonists or negative antagonists of a G protein coupled receptor (U.S. Patent Number 6,403,305)

   The present invention is directed to a strategy to discover small peptides that will activate any G protein coupled receptor (GPCR) or inactivate any constitutively active GPCR. The strategy uses combinatorial peptide libraries to screen millions of…
   Summary
   PI: Gershengorn, Marvin

6. Pituitary TRH receptor (U.S. Patent Number 5,288,621)

   Disclosed for the first time is the isolation, sequence, and expression cloning of a cDNA encoding for pituitary thyrotropin-releasing hormone receptor, as well as the amino acid sequence for the receptor per se
   Summary
   PI: Gershengorn, Marvin

7. Receptors that regulate cell signaling relating to chemokines (U.S. Patent Number 6,365,356)

   A method for discovering molecules that regulate cell signaling specific to the dual presence of Duffy antigen receptor for chemokines (DARC) and a chemokine receptor selected from the group consisting of a CXC receptor, a CC receptor and a CXXXC…
   Summary
   PI: Gershengorn, Marvin